Better survival in patients with metastasised kidney cancer after nephrectomy: a population-based study in the Netherlands
KKH Aben, S Heskamp, ML Janssen-Heijnen… - European Journal of …, 2011 - Elsevier
AIM: Cytoreductive nephrectomy is considered beneficial in patients with metastasised
kidney cancer but only a minority of these patients undergo cytoreductive surgery. Factors …
kidney cancer but only a minority of these patients undergo cytoreductive surgery. Factors …
Do metastatic kidney cancer patients benefit from cytoreductive nephrectomy? A real-world retrospective study from the SEER database
C Li, R Wang, W Ma, S Liu, X Yao - Frontiers in Surgery, 2021 - frontiersin.org
Introduction: The benefit of cytoreductive nephrectomy (CN) for metastatic kidney cancer has
been challenged recently. The study aimed to evaluate the prognostic roles of surgical …
been challenged recently. The study aimed to evaluate the prognostic roles of surgical …
Can we better select patients with metastatic renal cell carcinoma for cytoreductive nephrectomy?
SH Culp, NM Tannir, EJ Abel, V Margulis, P Tamboli… - Cancer, 2010 - Wiley Online Library
BACKGROUND: The benefits of cytoreductive nephrectomy (CN) in metastatic renal cell
carcinoma (mRCC) should outweigh surgical morbidity. Even when the generally agreed …
carcinoma (mRCC) should outweigh surgical morbidity. Even when the generally agreed …
Population-based assessment of survival after cytoreductive nephrectomy versus no surgery in patients with metastatic renal cell carcinoma
L Zini, U Capitanio, P Perrotte, C Jeldres, SF Shariat… - Urology, 2009 - Elsevier
OBJECTIVES: To examine the population-based survival rates of patients with metastatic
renal cell carcinoma (RCC) treated with cytoreductive nephrectomy (CNT) and compare …
renal cell carcinoma (RCC) treated with cytoreductive nephrectomy (CNT) and compare …
Surgical intervention in patients with metastatic renal cancer: current status of metastasectomy and cytoreductive nephrectomy
P Russo - Nature Clinical Practice Urology, 2004 - nature.com
It is estimated that in 2004 there will be 35,700 new cases of, and 12,480 deaths from,
kidney cancer in the US. Since 1950 there has been a 126% increase in the incidence of …
kidney cancer in the US. Since 1950 there has been a 126% increase in the incidence of …
Cytoreductive nephrectomy for metastatic renal cell carcinoma: A population‐based analysis of perioperative outcomes according to clinical stage
T Takagi, T Sugihara, H Yasunaga… - … Journal of Urology, 2014 - Wiley Online Library
Objectives To investigate the perioperative outcomes of cytoreductive nephrectomy
according to clinical T stage, and to analyze factors affecting these outcomes. Methods The J …
according to clinical T stage, and to analyze factors affecting these outcomes. Methods The J …
Analysis of pre-operative variables for identifying patients who might benefit from upfront cytoreductive nephrectomy for metastatic renal cell carcinoma in the targeted …
D You, IG Jeong, C Song, JL Lee… - Japanese Journal of …, 2015 - academic.oup.com
Objective The aim of the study is to identify pre-operative variables for selection of patients
who would benefit from upfront cytoreductive nephrectomy for metastatic renal cell …
who would benefit from upfront cytoreductive nephrectomy for metastatic renal cell …
The value of cytoreductive nephrectomy on the survival of metastatic renal carcinoma patients based on the number of site-specific metastases
Z Zhao, W Wu, X Duan, G Zeng, Y Liu - PLoS One, 2019 - journals.plos.org
Background There has been significant uncertainty in the selection of candidates for
cytoreductive nephrectomy (CN) in patients with metastatic renal cell carcinoma (mRCC) …
cytoreductive nephrectomy (CN) in patients with metastatic renal cell carcinoma (mRCC) …
Cytoreductive nephrectomy in metastatic renal cell carcinoma
V Margulis, SF Matin, CG Wood - Current opinion in urology, 2008 - journals.lww.com
Cytoreductive nephrectomy in metastatic renal cell carcinoma : Current Opinion in Urology
Cytoreductive nephrectomy in metastatic renal cell carcinoma : Current Opinion in Urology Log …
Cytoreductive nephrectomy in metastatic renal cell carcinoma : Current Opinion in Urology Log …
Outcomes of cytoreductive nephrectomy for patients with metastatic renal cell carcinoma: real world data from canadian centers
A Dragomir, S Nazha, S Tanguay, RH Breau… - European urology …, 2022 - Elsevier
Background Treatment options for metastatic renal cell carcinoma (mRCC) include
cytoreductive nephrectomy (CN) and systemic therapy (ST). Results from the CARMENA …
cytoreductive nephrectomy (CN) and systemic therapy (ST). Results from the CARMENA …